EP1504116A1 - Method and reagent system having an inactivated enzyme - Google Patents
Method and reagent system having an inactivated enzymeInfo
- Publication number
- EP1504116A1 EP1504116A1 EP03752757A EP03752757A EP1504116A1 EP 1504116 A1 EP1504116 A1 EP 1504116A1 EP 03752757 A EP03752757 A EP 03752757A EP 03752757 A EP03752757 A EP 03752757A EP 1504116 A1 EP1504116 A1 EP 1504116A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- coenzyme
- enzyme
- dehydrogenase
- analyte
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 34
- 102000004190 Enzymes Human genes 0.000 title claims description 31
- 108090000790 Enzymes Proteins 0.000 title claims description 31
- 239000005515 coenzyme Substances 0.000 claims abstract description 54
- 238000001514 detection method Methods 0.000 claims abstract description 40
- 239000012491 analyte Substances 0.000 claims abstract description 23
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 14
- 102000014914 Carrier Proteins Human genes 0.000 claims abstract description 11
- 108091008324 binding proteins Proteins 0.000 claims abstract description 11
- 239000011159 matrix material Substances 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 230000003197 catalytic effect Effects 0.000 claims description 8
- 101710088194 Dehydrogenase Proteins 0.000 claims description 7
- 108090000854 Oxidoreductases Proteins 0.000 claims description 6
- 102000004316 Oxidoreductases Human genes 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 5
- 102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 4
- 108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 4
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 4
- 238000007385 chemical modification Methods 0.000 claims description 4
- 230000035772 mutation Effects 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 3
- 229960002715 nicotine Drugs 0.000 claims description 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 238000006479 redox reaction Methods 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 2
- YPZRHBJKEMOYQH-UYBVJOGSSA-N FADH2 Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-N 0.000 claims description 2
- YTNIXZGTHTVJBW-SCRDCRAPSA-N FMNH2 Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2NC2=C1NC(=O)NC2=O YTNIXZGTHTVJBW-SCRDCRAPSA-N 0.000 claims description 2
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 claims description 2
- 108030000198 L-amino-acid dehydrogenases Proteins 0.000 claims description 2
- 102000013460 Malate Dehydrogenase Human genes 0.000 claims description 2
- 108010026217 Malate Dehydrogenase Proteins 0.000 claims description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 210000001124 body fluid Anatomy 0.000 claims description 2
- 239000010839 body fluid Substances 0.000 claims description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 claims description 2
- 150000004059 quinone derivatives Chemical class 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 description 21
- 235000018102 proteins Nutrition 0.000 description 12
- 239000000523 sample Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- -1 flavin nucleoside derivatives Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000002983 circular dichroism Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MAGFQRLKWCCTQJ-UHFFFAOYSA-N 4-ethenylbenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(C=C)C=C1 MAGFQRLKWCCTQJ-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 108010089254 Cholesterol oxidase Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000024135 NADH binding proteins Human genes 0.000 description 1
- 108091012742 NADH binding proteins Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/002—Electrode membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Definitions
- the invention relates to a method and a reagent system for the detection of an analyte in a sample by an enzymatic reaction, comprising the use of a detection reagent which contains a coenzyme and a catalytically inactive coenzyme-binding protein.
- the detection of analytes, for example glucose in blood, by enzymatic methods is known.
- the analyte to be determined is mixed with a detection reagent that contains a detectable by an enzymatic reaction, e.g. reducible or oxidizable, containing coenzyme, brought into contact.
- a detection reagent that contains a detectable by an enzymatic reaction, e.g. reducible or oxidizable, containing coenzyme, brought into contact.
- the redox equivalents that result from the reduction or oxidation of the coenzyme can be transferred to mediators, which are then recorded electrochemically or photometrically in a further step.
- a calibration provides a direct relationship between the measured value and the concentration of the analyte to be determined.
- mediators on the one hand require the use of complex reaction mixtures, which lead to a low stability and a high susceptibility to interference of the detection reaction, on the other hand mediators are often required in order to be able to carry out a detection or a sufficient one To achieve detection sensitivity.
- the object underlying the present invention was to at least partially avoid the disadvantages of the prior art described.
- an insensitive and sensitive Methods for the detection of analytes are provided, which leads to reliable measurement results even in the absence of mediators.
- a catalytically inactive coenzyme-binding protein is added to the other constituents of an enzymatic detection reagent.
- the catalytically inactive protein is able to bind a coenzyme modified by reaction of the analyte and thus to improve its detectability, in particular by optical methods.
- the invention thus relates to a method for the detection of an analyte in a sample by an enzymatic reaction, comprising the steps:
- the invention further relates to a reagent system for the detection of an analyte in a sample, comprising: (a) a coenzyme and (b) a catalytically inactive coenzyme-binding protein.
- the present invention enables simple qualitative or quantitative determination of analytes by an enzymatic reaction.
- the method is suitable for the detection of any analytes that can be detected by an enzymatic reaction with the participation of a coenzyme.
- the method according to the invention is distinguished from known methods in that the Detection reagent a catalytically inactive coenzyme-binding protein is added, whereby an improved detection sensitivity is brought about.
- the detection reagent contains the catalytically inactive protein in a sufficient amount to enable improved sensitivity in a qualitative and / or quantitative determination of the analyte in accordance with the desired test format. Since the method according to the invention preferably detects the coenzyme modified by the enzymatic reaction, in many cases the presence of mediators or other substances which can bring about regeneration of the coenzyme is not necessary.
- the method and the detection system allow the use of very small sample quantities, for example sample volumes ⁇ 1 ⁇ ⁇ , preferably ⁇ 0, 1 ⁇ ⁇ . If necessary, the sample can be diluted before contact with the detection reagent.
- the method and detection system according to the invention is suitable for determining any analyte, for example parameters in biological samples, such as body fluids, such as blood, serum, plasma or urine, but also in waste water samples or food.
- the method can be used both as a wet test, e.g. in a cuvette, or as a dry test on an appropriate reagent carrier.
- any biological or chemical substances that can be determined by an enzymatic reaction such as enzymes or enzyme substrates, can be selected as the analyte, the reaction comprising, in particular, a redox reaction.
- suitable analytes are, for example, glucose, lactic acid, malic acid, glycerol, alcohol, cholesterol, triglycerides, ascorbic acid, cysteine, glutathione, peptides etc.
- the enzymatic reaction is preferably a redox reaction in which the coenzyme to be detected is reduced or oxidized.
- an oxidoreductase is preferably used as the enzyme in the detection reagent.
- a dehydrogenase is particularly preferably used as the enzyme, for example selected from a glucose dehydrogenase (EC1 .1 .1 .47), lactate dehydrogenase (EC1 .1 .1 .27, 1 .1 .1 .28), malate dehydrogenase ⁇ EC1 .1 .1 .37), glycerol dehydrogenase (EC1 .1 .1 .6), alcohol dehydrogenase (EC1 .1 .1 .1) or amino acid dehydrogenase, e.g. L-amino acid dehydrogenase (EC1 .4.1 .5).
- Other suitable enzymes are oxidases, such as glucose oxidase (EC1 .1 .3.4) or cholesterol oxidase (EC1 .1 .3.6).
- the detection reaction is preferably a reduction or oxidation and an oxidoreductase is detected as an enzyme.
- Coenzymes in the sense of the present invention are preferably organic molecules which are covalently or non-covalently bound to an enzyme and which are changed, for example oxidized or reduced, by the reaction of the analyte.
- Preferred examples of coenzymes are flavin, nicotine and quinone derivatives, for example flavin nucleoside derivatives such as FAD, FADH 2 , FMN, FMNH 2 , etc., nicotine nucleoside derivatives such as NAD + , NADH / FT, NADP + , NADPH / FT etc. or Ubiquinones, such as coenzyme Q, PQQ etc.
- NADH / H + is particularly preferred as the coenzyme.
- the change in the coenzyme by reaction with the analyte can in principle be detected in any manner. In principle, all methods known from the prior art for the detection of enzymatic reactions can be used here. Preferably however, the change in the coenzyme is detected by optical methods. Optical detection methods include, for example, the measurement of absorption, fluorescence, circular dichroism (CD), optical rotation dispersion (ORD) or refractometry. The change in the coenzyme is particularly preferably detected by measuring the fluorescence. The fluorescence measurement is highly sensitive and enables the detection of even low concentrations of the analyte in miniaturized systems.
- the detectability is improved, in particular by optical methods.
- the binding of the coenzyme to a catalytically inactive protein leads in particular to an improved fluorescence yield of the coenzyme.
- the method or detection system according to the invention can comprise a liquid test, the reagent e.g. is in the form of a solution or suspension in an aqueous or non-aqueous liquid or as a powder or lyophilisate.
- the method and detection system according to the invention preferably includes a dry test, the reagent being applied to a support.
- the carrier can comprise, for example, a test strip comprising an absorbent and / or swellable material which is wetted by the sample liquid to be examined.
- the catalytically inactive coenzyme-binding protein is able to bind the coenzyme formed as the product of the enzymatic detection reaction, whereby the binding of the coenzyme results in an improved detectability of the coenzyme reaction product.
- the catalytically inactive protein is preferably an inactivated enzyme or a fragment of an inactivated enzyme which is not catalytically active but still contains a coenzyme binding site.
- an inactivated oxidoreductase e.g. B. an inactivated dehydrogenase.
- an inactivated NADH-binding dehydrogenase such as glucose dehydrogenase, is particularly preferred.
- Inactivation of enzymes can be brought about by mutations in the amino acid sequence, for example deletions, insertions and / or substitutions of individual amino acids or sections of several amino acids.
- a mutation takes place in the catalytic center of the enzyme.
- glucose dehydrogenase can be mutagenized on the histidine residue at position 14, which is essential for the catalytic activity, for example to serine or tryptophan.
- the enzyme can also be inactivated by chemical modifications, for example chemical modifications in the catalytic center, by which the catalytic activity is at least largely eliminated, while the ability to bind the coenzyme is retained.
- the detection reagent is stored in a matrix, for example in an absorbent material or in a gel matrix.
- the gel matrix preferably has a layer thickness of ⁇ 50 ⁇ m, in particular ⁇ 5 ⁇ m, and is applied to a carrier, for example an at least partially optically transparent carrier.
- the gel matrix is preferably a polymer which is based on photopolymerizable monomers, such as acrylic monomers, for example acrylamide or / and acrylic esters, such as polyethylene glycol diacrylate, or vinyl aromatic monomers, for example 4-vinylbenzenesulfonic acid, or combinations thereof.
- a liquid containing the reagent comprising a coenzyme, a catalytically inactive protein can be used to produce such a gel matrix or contains several photopolymerizable monomers and optionally enzyme, photoinitiator and / or non-reactive constituents, applied to an at least partially optically transparent support, for example on a plastic film, and irradiated, for example, with UV light from the back, so that the monomer polymerizes or the monomers on the carrier take place up to a predetermined layer thickness.
- the layer thickness can be controlled by adding absorbent substances to the reagent and / or by the duration or intensity of the irradiation. Excess liquid reagent can be removed after the polymerization and used again.
- the matrix can also be produced by conventional coating procedures, the liquid reagent being applied to a support, there using suitable methods, e.g. with a doctor blade, brought to the desired thickness and then dried or completely polymerized.
- the catalytically inactive protein and possibly the enzyme are in a protected microenvironment. If the polymeric gel matrix is sufficiently cross-linked, the protein molecules are in an immobilized form. Low molecular weight substances or glucose or other analytes or also coenzymes can diffuse freely through the polymer network.
- the catalytically inactive protein and optionally the enzyme can be polymerized into the matrix together with the coenzyme, or the matrix can be brought into contact with a solution of the coenzyme after the polymerization, so that it can diffuse into the matrix.
- the coenzyme modified, for example reduced or oxidized, by the reaction is optimally protected from interferences by binding to the inactive protein and, if appropriate, additionally by incorporation into the gel matrix. Furthermore, the present invention is to be explained in more detail by the following example.
- the essential histidine of GlucDH at position 147 was exchanged for serine by known methods.
Abstract
Description
Claims
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2002121845 DE10221845A1 (en) | 2002-05-16 | 2002-05-16 | Detecting analyte by enzymatic reaction, useful specifically for measuring glucose in blood, based on reaction with enzyme-coenzyme complex |
DE10221846 | 2002-05-16 | ||
DE2002121840 DE10221840A1 (en) | 2002-05-16 | 2002-05-16 | Production of polymer layers on a transparent support, for use in sensors, e.g. for blood analysis, comprises coating the support with a photopolymerizable liquid composition and irradiating the liquid through the support |
DE2002121846 DE10221846A1 (en) | 2002-05-16 | 2002-05-16 | Detecting an analyte by enzymatic reaction, useful specifically for measuring glucose in blood, based on reaction with coenzyme and inactive coenzyme-binding protein |
DE10221845 | 2002-05-16 | ||
DE10221840 | 2002-05-16 | ||
PCT/EP2003/005177 WO2003097863A1 (en) | 2002-05-16 | 2003-05-16 | Method and reagent system having an inactivated enzyme |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1504116A1 true EP1504116A1 (en) | 2005-02-09 |
Family
ID=29553736
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03752757A Withdrawn EP1504116A1 (en) | 2002-05-16 | 2003-05-16 | Method and reagent system having an inactivated enzyme |
EP03732396A Withdrawn EP1504115A1 (en) | 2002-05-16 | 2003-05-16 | Method and reagent system having a non-regenerative enzyme-coenzyme complex |
EP03730061A Expired - Lifetime EP1504113B1 (en) | 2002-05-16 | 2003-05-16 | Method for producing polymer layers |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03732396A Withdrawn EP1504115A1 (en) | 2002-05-16 | 2003-05-16 | Method and reagent system having a non-regenerative enzyme-coenzyme complex |
EP03730061A Expired - Lifetime EP1504113B1 (en) | 2002-05-16 | 2003-05-16 | Method for producing polymer layers |
Country Status (15)
Country | Link |
---|---|
US (3) | US8846132B2 (en) |
EP (3) | EP1504116A1 (en) |
JP (4) | JP2005532796A (en) |
KR (2) | KR101164048B1 (en) |
CN (2) | CN1653189B (en) |
AT (1) | ATE345396T1 (en) |
AU (3) | AU2003240666B2 (en) |
BR (2) | BR0311175A (en) |
CA (2) | CA2493918C (en) |
DE (1) | DE50305687D1 (en) |
DK (1) | DK1504113T3 (en) |
ES (1) | ES2275095T3 (en) |
HK (2) | HK1081599A1 (en) |
MX (2) | MXPA04011103A (en) |
WO (3) | WO2003097863A1 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005532796A (en) * | 2002-05-16 | 2005-11-04 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Method and reagent system having a non-renewable enzyme-coenzyme complex |
DE10325699B3 (en) * | 2003-06-06 | 2005-02-10 | Roche Diagnostics Gmbh | System for analyzing a sample to be tested and using such a system |
DE102004007983A1 (en) * | 2004-02-18 | 2005-09-08 | Roche Diagnostics Gmbh | Test element with single-layer reaction film |
DE102004051830B4 (en) * | 2004-10-25 | 2007-12-13 | Roche Diagnostics Gmbh | Multifunctional reference system for analyte determination by fluorescence |
US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
DE102005035461A1 (en) | 2005-07-28 | 2007-02-15 | Roche Diagnostics Gmbh | Stable NAD / NADH derivatives |
JP5147702B2 (en) | 2005-09-30 | 2013-02-20 | インテュイティ メディカル インコーポレイテッド | Fully integrated wearable or handheld monitor |
CA2564666A1 (en) * | 2005-10-25 | 2007-04-25 | F. Hoffmann-La Roche Ag | Fluorescence spectroscopy in absorbing media |
GB0526051D0 (en) | 2005-12-21 | 2006-02-01 | Oxford Biosensors Ltd | Cholesterol sensor |
EP1830177A1 (en) | 2006-03-02 | 2007-09-05 | F. Hoffman-la Roche AG | Integrated test element |
US20100056740A1 (en) * | 2006-06-14 | 2010-03-04 | Brigham Young University | Adsorption-resistant acrylic copolymer for fluidic devices |
EP2022859A1 (en) * | 2007-08-01 | 2009-02-11 | Roche Diagnostics GmbH | Method and device for determining the concentration of an analyte using measurement of fluorescence |
EP2093284A1 (en) | 2008-02-19 | 2009-08-26 | F.Hoffmann-La Roche Ag | Stabilisation of dehydrogenases with stable coenzymes |
US9833183B2 (en) | 2008-05-30 | 2017-12-05 | Intuity Medical, Inc. | Body fluid sampling device—sampling site interface |
JP5642066B2 (en) | 2008-06-06 | 2014-12-17 | インテュイティ メディカル インコーポレイテッド | Method and apparatus for performing an assay to determine the presence or concentration of an analyte contained in a sample of body fluid |
CA2730544C (en) | 2008-07-11 | 2017-08-29 | Universal Biosensors Pty Ltd | Enhanced immunoassay sensor |
EP2398909B1 (en) | 2009-02-19 | 2015-07-22 | F. Hoffmann-La Roche AG | Fast reaction kinetics of enzymes having low activity in dry chemistry layers |
WO2010094427A2 (en) | 2009-02-19 | 2010-08-26 | Roche Diagnostics Gmbh | Compact storage of auxiliary analytical devices in a cartridge |
EP2226008A1 (en) | 2009-02-19 | 2010-09-08 | Roche Diagnostics GmbH | Method for producing an analytical magazine |
EP2226007A1 (en) | 2009-02-19 | 2010-09-08 | Roche Diagnostics GmbH | Test element magazine with covered test fields |
EP2292751A1 (en) | 2009-08-20 | 2011-03-09 | Roche Diagnostics GmbH | Stabilisation of enzymes with stable coenzymes |
EP2506768B1 (en) | 2009-11-30 | 2016-07-06 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
EP2362207A1 (en) * | 2010-01-28 | 2011-08-31 | F. Hoffmann-La Roche AG | Measuring system and method, in particular for determining blood sugar |
US9752990B2 (en) | 2013-09-30 | 2017-09-05 | Honeywell International Inc. | Low-powered system for driving a fuel control mechanism |
EP2696764B1 (en) | 2011-04-12 | 2015-10-14 | Roche Diagnostics GmbH | Analytical aid |
WO2013020103A1 (en) | 2011-08-03 | 2013-02-07 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
EP2620507A1 (en) | 2012-01-25 | 2013-07-31 | Roche Diagnostics GmbH | Method for the evaluation of the quality of a test element |
WO2013156526A1 (en) | 2012-04-19 | 2013-10-24 | F. Hoffmann-La Roche Ag | Method and device for determining an analyte concentration in blood |
DE102013104906B4 (en) * | 2013-05-13 | 2015-06-25 | Brandenburgische Technische Universität Cottbus-Senftenberg | Anhydrous immobilization of enzymes |
EP3004372A1 (en) | 2013-06-04 | 2016-04-13 | Roche Diagnostics GmbH | Novel compounds useful for fret and methods related thereto |
SG11201700876RA (en) * | 2014-08-05 | 2017-03-30 | Becton Dickinson Co | Methods and compositions for analyzing glucose-6-phosphate dehydrogenase activity in blood samples |
KR102273051B1 (en) | 2014-10-21 | 2021-07-06 | 삼성디스플레이 주식회사 | Compound for hole transporting and organic light emitting device utilizing same |
EP3339431A1 (en) | 2016-12-22 | 2018-06-27 | Roche Diabetes Care GmbH | Glucose dehydrogenase variants with improved properties |
WO2020064723A1 (en) * | 2018-09-24 | 2020-04-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Tailored layers of cellulose dispersions for detecting analytes |
US11579093B2 (en) | 2020-04-22 | 2023-02-14 | SciLogica Corp. | Optical component |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE638336A (en) * | 1964-12-21 | 1964-02-03 | ||
CS164231B2 (en) * | 1972-09-28 | 1975-11-07 | ||
DE2924249C2 (en) * | 1978-06-22 | 1989-04-27 | Miles, Inc., Elkhart, Ind., Us | SPECIFIC BINDING INVESTIGATION METHOD FOR DETERMINING LIGAND IN A FLUID MEDIUM AND REAGENTS FOR CARRYING OUT THIS METHOD |
US4238565A (en) | 1978-06-22 | 1980-12-09 | Miles Laboratories, Inc. | Specific binding assay with a prosthetic group as a label component |
AT367796B (en) * | 1979-10-29 | 1982-07-26 | List Hans | METHOD FOR DETERMINING A SUBSTANCE CONCENTRATION IN A SOLUTION |
US4451568A (en) * | 1981-07-13 | 1984-05-29 | Battelle Memorial Institute | Composition for binding bioactive substances |
DE3332144A1 (en) * | 1982-09-06 | 1984-03-08 | Konishiroku Photo Industry Co., Ltd., Tokyo | Analytical element |
DE3477849D1 (en) * | 1983-12-06 | 1989-05-24 | Ici Plc | Dry film resists |
US4820399A (en) * | 1984-08-31 | 1989-04-11 | Shimadzu Corporation | Enzyme electrodes |
GB8608435D0 (en) * | 1986-04-07 | 1986-05-14 | Cranfield Inst Of Tech | Specific binding assays |
JPH0710896B2 (en) | 1987-04-30 | 1995-02-08 | 第一工業製薬株式会社 | Method for producing high molecular weight cationic acrylic polymer |
GB8718430D0 (en) * | 1987-08-04 | 1987-09-09 | Ici Plc | Sensor |
AU602277B2 (en) * | 1988-02-10 | 1990-10-04 | Miles Inc. | Self-indicating and improved resolution analyses employing stoichiometric chemical substraction |
US5340722A (en) * | 1988-08-24 | 1994-08-23 | Avl Medical Instruments Ag | Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method |
US5296305A (en) * | 1990-05-11 | 1994-03-22 | Esslior International (Compagnie Generale D'optique) | Method of fabricating a lens made of transparent polymer with modulated refracting index |
GB9022304D0 (en) * | 1990-10-15 | 1990-11-28 | Ares Serono Res & Dev Ltd | Assay technique |
JP2977265B2 (en) * | 1990-11-19 | 1999-11-15 | 旭化成工業株式会社 | Photosensitive elastomer composition |
DE4118880C2 (en) | 1991-06-08 | 1998-12-17 | Fraunhofer Ges Forschung | Method for the selective determination of the concentration of dissolved substances in enzymatic reactions |
JPH06506019A (en) * | 1991-12-18 | 1994-07-07 | シメッド ライフ システムズ インコーポレイテッド | Lubricious polymer network |
DE59307720D1 (en) * | 1992-03-23 | 1998-01-08 | Siemens Ag | Biosensor |
JPH07115997A (en) | 1993-08-31 | 1995-05-09 | Iatron Lab Inc | Reagent for gpt determination |
JPH07115998A (en) | 1993-08-31 | 1995-05-09 | Iatron Lab Inc | Reagent for got determination |
US5447847A (en) * | 1993-09-02 | 1995-09-05 | Nissui Pharmaceutical Co., Ltd. | Quantitative determination of pyruvic acid and quantitative analysis for component of living body making use of such determination |
GB9404805D0 (en) * | 1994-03-11 | 1994-04-27 | Minnesota Mining & Mfg | Novel developing agents for (photo)thermographic systems |
JP2986712B2 (en) * | 1995-05-01 | 1999-12-06 | キヤノン株式会社 | Chemical sensor, apparatus and method for measuring chloride ion concentration using the same |
US5691205A (en) * | 1994-06-23 | 1997-11-25 | Canon Kabushiki Kaisha | Fluorometric analysis of chloride ion and chemical sensor therefor |
DE4424179C2 (en) * | 1994-07-08 | 1998-09-10 | Biotechnolog Forschung Gmbh | UV-polymerizable enzyme paste for the production of thick-film biosensors and thick-film biosensors produced therewith |
JPH09248200A (en) | 1996-03-13 | 1997-09-22 | Nissho Corp | Reagent for assaying glucose |
US5863650A (en) * | 1997-05-05 | 1999-01-26 | Bioengineered Materials, Inc. | Interfacial coatings |
JP2000035413A (en) | 1998-07-16 | 2000-02-02 | Sapporo Imuno Diagnostic Laboratory:Kk | Biosensor using dehydrogenase and coenzyme |
AT409307B (en) | 1999-01-12 | 2002-07-25 | Hoffmann La Roche | OPTICAL-CHEMICAL SENSOR |
JP3869601B2 (en) | 1999-11-26 | 2007-01-17 | 株式会社トクヤマ | Method for measuring homocysteine |
US6635412B2 (en) * | 2000-07-11 | 2003-10-21 | Martin A. Afromowitz | Method for fabricating 3-D structures with smoothly-varying topographic features in photo-sensitized epoxy resists |
WO2002052045A1 (en) | 2000-12-26 | 2002-07-04 | Aviva Biosciences | Active and biocompatible platforms prepared by polymerization of surface coating films |
US20030087178A1 (en) * | 2001-04-20 | 2003-05-08 | Adrian Lungu | Photopolymerizable element for use as a flexographic printing plate and a process for preparing the plate from the element |
JP2005532796A (en) * | 2002-05-16 | 2005-11-04 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Method and reagent system having a non-renewable enzyme-coenzyme complex |
US7553615B2 (en) * | 2005-07-28 | 2009-06-30 | Roche Diagnostics Operations, Inc. | Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH |
EP1964927A1 (en) * | 2007-02-27 | 2008-09-03 | F. Hoffmann-La Roche AG | Quinones as mediators for photometric tests |
US20080219811A1 (en) * | 2007-03-05 | 2008-09-11 | Van Der Meulen Peter | Semiconductor manufacturing process modules |
EP2022859A1 (en) * | 2007-08-01 | 2009-02-11 | Roche Diagnostics GmbH | Method and device for determining the concentration of an analyte using measurement of fluorescence |
-
2003
- 2003-05-16 JP JP2004506519A patent/JP2005532796A/en active Pending
- 2003-05-16 CA CA2493918A patent/CA2493918C/en not_active Expired - Fee Related
- 2003-05-16 MX MXPA04011103A patent/MXPA04011103A/en active IP Right Grant
- 2003-05-16 US US10/514,758 patent/US8846132B2/en active Active
- 2003-05-16 AU AU2003240666A patent/AU2003240666B2/en not_active Ceased
- 2003-05-16 KR KR1020047018213A patent/KR101164048B1/en not_active IP Right Cessation
- 2003-05-16 AU AU2003240260A patent/AU2003240260B2/en not_active Ceased
- 2003-05-16 US US10/514,451 patent/US7341830B2/en not_active Expired - Fee Related
- 2003-05-16 MX MXPA04011220A patent/MXPA04011220A/en active IP Right Grant
- 2003-05-16 WO PCT/EP2003/005177 patent/WO2003097863A1/en active Application Filing
- 2003-05-16 WO PCT/EP2003/005179 patent/WO2003097859A2/en active IP Right Grant
- 2003-05-16 CN CN038110814A patent/CN1653189B/en not_active Expired - Fee Related
- 2003-05-16 BR BR0311175-0A patent/BR0311175A/en not_active IP Right Cessation
- 2003-05-16 DK DK03730061T patent/DK1504113T3/en active
- 2003-05-16 AT AT03730061T patent/ATE345396T1/en active
- 2003-05-16 CN CNB038110679A patent/CN100439513C/en not_active Expired - Fee Related
- 2003-05-16 ES ES03730061T patent/ES2275095T3/en not_active Expired - Lifetime
- 2003-05-16 JP JP2004506518A patent/JP4656938B2/en not_active Expired - Fee Related
- 2003-05-16 EP EP03752757A patent/EP1504116A1/en not_active Withdrawn
- 2003-05-16 BR BRPI0309947-4B1A patent/BR0309947B1/en not_active IP Right Cessation
- 2003-05-16 CA CA2486950A patent/CA2486950C/en not_active Expired - Fee Related
- 2003-05-16 DE DE50305687T patent/DE50305687D1/en not_active Expired - Lifetime
- 2003-05-16 JP JP2004506514A patent/JP5118288B2/en not_active Expired - Fee Related
- 2003-05-16 EP EP03732396A patent/EP1504115A1/en not_active Withdrawn
- 2003-05-16 AU AU2003232790A patent/AU2003232790A1/en not_active Abandoned
- 2003-05-16 KR KR1020047018212A patent/KR101002194B1/en not_active IP Right Cessation
- 2003-05-16 WO PCT/EP2003/005178 patent/WO2003097864A1/en active Application Filing
- 2003-05-16 EP EP03730061A patent/EP1504113B1/en not_active Expired - Lifetime
-
2006
- 2006-02-07 HK HK06101610.2A patent/HK1081599A1/en not_active IP Right Cessation
- 2006-02-08 HK HK06101676.3A patent/HK1081600A1/en not_active IP Right Cessation
-
2008
- 2008-01-10 US US12/008,283 patent/US7951581B2/en not_active Expired - Fee Related
-
2009
- 2009-08-19 JP JP2009190529A patent/JP2009275233A/en active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO03097863A1 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1504116A1 (en) | Method and reagent system having an inactivated enzyme | |
US7189341B2 (en) | Electrochemical sensor ink compositions, electrodes, and uses thereof | |
EP1780288B1 (en) | Fluorescence spectroscopy in absorbing media | |
WO2013072275A1 (en) | Analytical apparatus for detecting at least one analyte in a sample | |
CN109520979B (en) | Method for detecting cholesterol in serum | |
JP4082505B2 (en) | Alcohol analysis method | |
EP2513648B1 (en) | Detection of the decomposition of enzymes in a test element through controlled release of protected analyte | |
AT390803B (en) | METHOD FOR DETERMINING THE CONCENTRATION OF AN ENZYME SUBSTRATE AND SENSOR FOR IMPLEMENTING THE METHOD | |
Vaidya et al. | Use of charged membranes to control interference by body chemicals in a glucose biosensor | |
DE10221845A1 (en) | Detecting analyte by enzymatic reaction, useful specifically for measuring glucose in blood, based on reaction with enzyme-coenzyme complex | |
DE10221846A1 (en) | Detecting an analyte by enzymatic reaction, useful specifically for measuring glucose in blood, based on reaction with coenzyme and inactive coenzyme-binding protein | |
JPH11253193A (en) | Test piece for assaying creatine kinase activity | |
EP1445603A1 (en) | Fluorometric Determination of Analytes with Amine-N-Oxides as Redox-Indicators | |
CA2473069A1 (en) | Castable diffusion membrane for enzyme-based sensor application | |
EP1502957B1 (en) | Castable diffusion membrane for enzyme-based sensor application | |
JP3186911B2 (en) | Determination of trace components | |
JP2010233545A (en) | Method for measuring polyol | |
DD228827A1 (en) | METHOD FOR DETERMINING SUBSTRATES OF COFACTOR-DEPENDENT DEHYDROGENASES | |
JP2006275759A (en) | Measuring method of substrate using biosensor | |
JPH03151898A (en) | Method for measuring flow injection utilizing immobilized enzyme | |
DE10221840A1 (en) | Production of polymer layers on a transparent support, for use in sensors, e.g. for blood analysis, comprises coating the support with a photopolymerizable liquid composition and irradiating the liquid through the support |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20041027 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20100607 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KNAPPE, WOLFGANG-REINHOLD Inventor name: HOENES, JOACHIM Inventor name: HORN, CARINA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20111011 |